Edwards Lifesciences vs Idexx Laboratories
Edwards Lifesciences (EW) and Idexx Laboratories (IDXX) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $60.5B
- Last close
- $105.23
- 12 months
- +25.2%
- Market value
- $55B
- Last close
- $698.47
- 12 months
- +4.2%
At a glance
- Edwards Lifesciences and Idexx Laboratories are close in size by market value ($60.5B and $55.0B).
- Over the last 12 months Edwards Lifesciences's share price moved +25.2% and Idexx Laboratories's +4.2%; against the S&P 500 that is +14.6 points and −6.4 points.
- In their last fiscal years Edwards Lifesciences kept 17.7% of revenue as net income and Idexx Laboratories 24.6%.
- In the last 90 days insiders reported 0 open-market purchases at Edwards Lifesciences and 0 at Idexx Laboratories; members of Congress disclosed 0 trades in Edwards Lifesciences and 0 in Idexx Laboratories.
- Next results: Edwards Lifesciences Feb 8, 2027, Idexx Laboratories Feb 1, 2027.
Share price over the last 12 months
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Edwards Lifesciences EWNYSE · Health Care Equipment | Idexx Laboratories IDXXNASDAQ · Health Care Equipment | |
|---|---|---|
| Size and profitability | ||
| Market value | $60.5B | $55B |
| Revenue, last fiscal year | $6.07B | $4.3B |
| Net income, last fiscal year | $1.07B | $1.06B |
| Net marginNet income as a share of revenue | 17.7% | 24.6% |
| Free cash flow | $1.33B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Edwards Lifesciences against
Common questions
How is Edwards Lifesciences different from Idexx Laboratories?
Edwards Lifesciences (EW) is in Health Care Equipment on NYSE, with $6.07B of revenue in its last fiscal year and a net margin of 17.7%. Idexx Laboratories (IDXX) is in Health Care Equipment on NASDAQ, with $4.3B of revenue in its last fiscal year and a net margin of 24.6%. Both are in the same industry, so the gap is mostly one of size and profitability. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Edwards Lifesciences and Idexx Laboratories compare in size?
Edwards Lifesciences has the larger market value: Edwards Lifesciences $60.5B and Idexx Laboratories $55B, at the last close.
Whose share price rose more over the last 12 months, EW or IDXX?
Over the last 12 months Edwards Lifesciences moved +25.2% and Idexx Laboratories +4.2%. Past price moves say nothing about the future.
Which has had more insider buying, Edwards Lifesciences or Idexx Laboratories?
Since 2006, Idexx Laboratories insiders reported 24 open-market purchases against 12 for Edwards Lifesciences. These are counts of what was filed, not a view on either stock.
Do members of Congress trade EW or IDXX?
In the last 12 months, members of Congress disclosed 2 trades in Edwards Lifesciences (EW) and 2 in Idexx Laboratories (IDXX).
When did insiders last buy EW and IDXX?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Edwards Lifesciences pageIdexx Laboratories pageRare insider trades this weekAll comparisons
https://oqro.io/compare/ew-vs-idxx







